Cargando…
A Novel Daratumumab-Based Regimen for Desensitization in Highly HLA-Presensitized Patients Awaiting Kidney Transplantation
Autores principales: | Zhao, Daqiang, Guo, Zhiliang, Zhao, Guangyuan, Sa, Rula, Zhu, Lan, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477353/ https://www.ncbi.nlm.nih.gov/pubmed/37675269 http://dx.doi.org/10.3389/ti.2023.11771 |
Ejemplares similares
-
A modified perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy
por: Guo, Zhiliang, et al.
Publicado: (2023) -
Immunoadsorption-Based HLA Desensitization in Patients Awaiting Deceased Donor Kidney Transplantation: An Interventional, Non-Randomised, Single Cohort Study
por: Bureau, Côme, et al.
Publicado: (2023) -
Case report: Daratumumab for treatment of refractory late or chronic active antibody-mediated rejection in renal allograft recipients with high levels of de novo donor-specific antibodies
por: Zhu, Lan, et al.
Publicado: (2023) -
Prime Time for HLA Desensitization: Imlifidase in the Spotlight
por: Bestard, Oriol, et al.
Publicado: (2023) -
Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA
por: Chung, Byung Ha, et al.
Publicado: (2015)